Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Apr 18, 2021 2:12pm
303 Views
Post# 33019265

Timothy Shelburn & Chad Dillow sold collection sites

Timothy Shelburn & Chad Dillow sold collection sites

So let me understand correctly, QuestCap publicly announced buying and then completing collection sites. They filed with regulators and CSE exchange at that. https://thecse.com/en/trading/market-activity/company-filings/questcap-closes-transaction-to-acquire-100-interest-in QuestCap paid 20 million shares to Timothy Shelburn, Chad Dillow and two others to buy collection sites. These records can be simply needed to be updated. You can even find documents filed showing who got, how many shares for 4 people who sold collection sites.

 

Medivolve filed a financial statement with about $7.5 million in revenue from the collection sites alone in the 4th quarter. Almost every news says Medivolve's primary focus is to provide convenient and assessable medical services for testing the COVID-19 virus to help combat the pandemic. This is achieved largely through two acquisitions: 100 percent of Collection Sites and 28 percent of Colombian Sanaty IPS. 

 

All that without owning collection sites. Lol

<< Previous
Bullboard Posts
Next >>